Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butylphthalide for acute pontine infarction
ChiCTR2600135301Phase 4Not yet recruiting
- Sponsor
- Wuxi People's Hospital
- Start
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of butylphthalide in Acute Pontine Infarction and ischemic stroke (2 arms), sponsored by Wuxi People's Hospital. Primary endpoints: Proportion of patients with mRS score 0-1 at 90 days and All-cause mortality within 90 days. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
butylphthalide
03
Conditions
Acute Pontine Infarctionischemic stroke
Beyond the preview
Go deeper on ChiCTR2600135301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600135301.